Clinical trial
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
NCT06244940 is registered in ClinicalTrials.gov with Scripps Translational Science Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
- Lead sponsor
- Scripps Translational Science Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 9, 2024
- Completion date
- October 1, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart disease